Obstetric outcome of patients with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer.

[1]  N. Goldenberg,et al.  Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin. , 2002, Human reproduction.

[2]  S. Ballas,et al.  The incidence of polyploid fertilization in patients with and without polycystic ovaries: is it a possible cause of early abortions? , 2002 .

[3]  H. Picton.  Oocyte maturation in vitro , 2002, Current opinion in obstetrics & gynecology.

[4]  J. Kurinczuk,et al.  The risk of major birth defects after intracytoplasmic sperm injection and in vitro fertilization. , 2002, The New England journal of medicine.

[5]  D. Jakubowicz,et al.  Effects of metformin on early pregnancy loss in the polycystic ovary syndrome , 2002, The Journal of clinical endocrinology and metabolism.

[6]  B. Gülekli,et al.  In vitro maturation and fertilization of oocytes from unstimulated normal ovaries, polycystic ovaries, and women with polycystic ovary syndrome. , 2001, Fertility and sterility.

[7]  S. Lindenberg,et al.  Benefit of FSH priming of women with PCOS to the in vitro maturation procedure and the outcome: a randomized prospective study. , 2001, Reproduction.

[8]  T. Mukherjee,et al.  The Egg or the Endometrium: Why Do PCO Patients Have Higher Rates of Miscarriage? , 2000 .

[9]  K. Cha,et al.  Pregnancies and deliveries after in vitro maturation culture followed by in vitro fertilization and embryo transfer without stimulation in women with polycystic ovary syndrome. , 2000, Fertility and sterility.

[10]  Seang Tan,et al.  Prospective randomized study of human chorionic gonadotrophin priming before immature oocyte retrieval from unstimulated women with polycystic ovarian syndrome. , 2000, Human reproduction.

[11]  C. Glueck,et al.  Plasminogen activator inhibitor activity: an independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome. , 1999, Metabolism: clinical and experimental.

[12]  J. Grudzinskas,et al.  Children born after intracytoplasmic sperm injection: population control study , 1999, BMJ.

[13]  S. Campbell,et al.  The outcome of in-vitro fertilization treatment in women with sonographic evidence of polycystic ovarian morphology. , 1999, Human reproduction.

[14]  T. Key,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study* , 2022 .

[15]  E. Diamanti-Kandarakis,et al.  Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome. , 1998, European journal of endocrinology.

[16]  J. Kurinczuk,et al.  Birth defects in infants conceived by intracytoplasmic sperm injection: an alternative interpretation , 1997, BMJ.

[17]  A. Trounson,et al.  In vitro maturation and the fertilization and developmental competence of oocytes recovered from untreated polycystic ovarian patients. , 1994, Fertility and sterility.

[18]  S. L. Tan,et al.  A controlled study comparing patients with and without polycystic ovaries undergoing in-vitro fertilization. , 1993, Human reproduction.

[19]  C. Racowsky,et al.  Nuclear degeneration and meiotic aberrations observed in human oocytes matured in vitro: analysis by light microscopy**Supported in part by grant 15-0803 from the March of Dimes Birth Defects Foundation, White Plains, New York. , 1992 .

[20]  J. Koo,et al.  Pregnancy after in vitro fertilization of human follicular oocytes collected from nonstimulated cycles, their culture in vitro and their transfer in a donor oocyte program. , 1991, Fertility and sterility.

[21]  E. Rudak,et al.  The treatment of patients with polycystic ovarian syndrome by in-vitro fertilization and embryo transfer: a comparison of results with those of patients with tubal infertility. , 1990, Human reproduction.